We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+3.93%
1 Year Est. Return
+46.46%
3 Year Est. Return
+108.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$13.7B
AUM Growth
+$1.01B
Cap. Flow
+$589M
Cap. Flow %
4.3%
Top 10 Hldgs %
11.63%
Holding
1,581
New
640
Increased
361
Reduced
263
Closed
311

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$90.4M
2
PFE icon
Pfizer
PFE
+$82.7M
3
MCD icon
McDonald's
MCD
+$65.4M
4
KDP icon
Keurig Dr Pepper
KDP
+$64.6M
5
ULTA icon
Ulta Beauty
ULTA
+$63.9M

Top Sells

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$225M
2
AMZN icon
Amazon
AMZN
+$144M
3
BCR
CR Bard Inc.
BCR
+$135M
4
ZTS icon
Zoetis
ZTS
+$121M
5
MJN
Mead Johnson Nutrition Company
MJN
+$120M

Sector Composition

Rank Sector Weight
1 Healthcare 20.96%
2 Technology 16.17%
3 Consumer Discretionary 15.54%
4 Industrials 10.23%
5 Financials 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACTG icon
1176
Acacia Research
ACTG
$445M
$268K ﹤0.01%
+67,071
New +$312K
PGC icon
1177
Peapack-Gladstone Financial
PGC
$827M
$267K ﹤0.01%
+8,610
New +$264K
AHL
1178
DELISTED
ASPEN Insurance Holding Limited
AHL
$267K ﹤0.01%
+5,342
New +$271K
PAGP icon
1179
Plains GP Holdings
PAGP
$5.04B
$264K ﹤0.01%
+10,138
New +$283K
OTLK icon
1180
Outlook Therapeutics
OTLK
$180M
$262K ﹤0.01%
1,636
– –
ABM icon
1181
ABM Industries
ABM
$2.88B
$261K ﹤0.01%
+6,212
New +$264K
OXM icon
1182
Oxford Industries
OXM
$579M
$259K ﹤0.01%
+4,183
New +$241K
PBH icon
1183
Prestige Consumer Healthcare
PBH
$2.46B
$257K ﹤0.01%
+4,839
New +$259K
HBAN icon
1184
Huntington Bancshares
HBAN
$35.5B
$256K ﹤0.01%
+18,311
New +$237K
TMP icon
1185
Tompkins Financial
TMP
$1.46B
$255K ﹤0.01%
+3,232
New +$260K
AMN icon
1186
AMN Healthcare
AMN
$1.29B
$252K ﹤0.01%
+6,467
New +$248K
MOV icon
1187
Movado Group
MOV
$879M
$252K ﹤0.01%
10,094
-7,911
-44% -$183K
MSBI icon
1188
Midland States Bancorp
MSBI
$717M
$249K ﹤0.01%
+7,333
New +$250K
TRQ
1189
DELISTED
Turquoise Hill Resources Ltd
TRQ
$249K ﹤0.01%
+8,307
New +$225K
BNCL
1190
DELISTED
Beneficial Bancorp, Inc.
BNCL
$249K ﹤0.01%
+16,610
New +$256K
TRS icon
1191
TriMas Corp
TRS
$1.45B
$248K ﹤0.01%
+11,812
New +$255K
NETI
1192
DELISTED
Eneti Inc.
NETI
$245K ﹤0.01%
+3,768
New +$247K
SLAB icon
1193
Silicon Laboratories
SLAB
$7.2B
$242K ﹤0.01%
+3,565
New +$258K
CBAY
1194
DELISTED
Cymabay Therapeutics
CBAY
$242K ﹤0.01%
+40,416
New +$172K
OAK
1195
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
$241K ﹤0.01%
+5,118
New +$237K
DLNG icon
1196
Dynagas LNG Partners
DLNG
$136M
$238K ﹤0.01%
+15,861
New +$250K
ANGI icon
1197
Angi Inc
ANGI
$251M
$237K ﹤0.01%
+1,823
New +$180K
ODFL icon
1198
Old Dominion Freight Line
ODFL
$45.6B
$237K ﹤0.01%
7,494
-187,623
-96% -$5.52M
ARCB icon
1199
ArcBest
ARCB
$3.23B
$236K ﹤0.01%
+11,236
New +$244K
MTN icon
1200
Vail Resorts
MTN
$5.33B
$236K ﹤0.01%
+1,167
New +$235K
46 47
48
49 50

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2017 Portfolio in Review

As of Q2 2017, Marshall Wace North America held 1,581 positions worth $13.7B, up 8% from $12.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace North America deployed $589M of net new capital in Q2 2017, opening 640 new positions and adding to 361 existing holdings. Its largest new stake was Ulta Beauty: 218,927 shares worth $62.8M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was T-Mobile US, an estimated $225M trimmed.

  • Marshall Wace North America's largest Q2 2017 buy was Ulta Beauty: 218,927 shares worth $62.8M.
  • Marshall Wace North America added most to Alphabet (Google) Class A in Q2 2017, an estimated $90.4M increase.
  • Marshall Wace North America's biggest Q2 2017 reduction was T-Mobile US, cutting an estimated $225M.
  • Marshall Wace North America fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $120M.
  • Marshall Wace North America's ten largest holdings make up 12% of its $13.7B portfolio in Q2 2017.
  • Marshall Wace North America opened 640 new positions and closed 311 in Q2 2017.
  • Marshall Wace North America's portfolio value rose 8% quarter-over-quarter to $13.7B.

Based on Marshall Wace North America's 13F filing for Q2 2017, filed 4 Aug 2017.